Drug Type Chemical drugs |
Synonyms |
Target |
Action inhibitors |
Mechanism 11β-HSD inhibitors(11-beta-hydroxysteroid dehydrogenase inhibitors), KMO inhibitors(kynurenine 3-monooxygenase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glaucoma | Discovery | South Korea | 11 Aug 2023 |